A Telix Pharmaceuticals expande as opções de tratamento do câncer adquirindo ativos de direcionamento FAP, com foco no câncer de bexiga. Telix Pharmaceuticals expands cancer treatment options by acquiring FAP-targeting assets, focusing on bladder cancer.

A Telix Pharmaceuticals planeja expandir seu pipeline de tratamento de câncer adicionando novos ativos que visam a proteína de ativação de fibroblastos (FAP), inicialmente com foco no câncer de bexiga. Telix Pharmaceuticals plans to expand its cancer treatment pipeline by adding new assets that target Fibroblast Activation Protein (FAP), initially focusing on bladder cancer. A empresa celebrou acordos para radiofármacos terapêuticos e diagnósticos direcionados a FAP, pagando 7 milhões inicialmente, com potencial para pagamentos adicionais com base em marcos. The company entered into agreements for FAP-targeting therapeutic and diagnostic radiopharmaceuticals, paying €7 million initially, with potential for additional payments based on milestones. Esses ativos visam melhorar os resultados de tratamento e diagnóstico, visando as células cancerígenas com mais precisão. These assets aim to improve treatment and diagnostic outcomes by targeting cancer cells more precisely.

November 18, 2024

7 Artigos